53 filings
Page 3 of 3
8-K
7zgljhh7r i6tg03
5 May 20
Regulation FD Disclosure
12:00pm
8-K
2auhaa4g
20 Mar 20
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
2:13pm
8-K
9lfwphm r6eax
26 Feb 20
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial Results
4:15pm
8-K
4ikan7w8oro
18 Feb 20
Departure of Directors or Certain Officers
7:00am
8-K/A
6v0f jm68gnq40nst14
24 Jan 20
Adaptive Announces Preliminary Unaudited Revenue for About Adaptive Biotechnologies
9:16pm
8-K
wdfb7ll zd1hjqlh
23 Jan 20
Adaptive Announces Proposed Public Offering of Common Stock
9:04pm
8-K
9g1zu bht
8 Jan 20
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia
9:00am
8-K
lbxq17 i83jnka41
12 Nov 19
Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results
4:15pm
8-K
gf5el0f61eq
24 Sep 19
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx
5:01pm
8-K
cmm59xx 9vf79t
13 Aug 19
Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
4:15pm
8-K
ahg6zd14da20wfg0c
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
8-K
dth vui2gykzbhw
2 Aug 19
Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect
4:54pm
8-K
s28bhm9ge e3ocd6
1 Jul 19
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
4:41pm